Translating metastasis-related biomarkers to the clinic--progress and pitfalls (Q38079125)

28 August 2017

1 reference

title

Translating metastasis-related biomarkers to the clinic--progress and pitfalls (English)

1 reference

28 August 2017

0 references

François-Clément Bidard

1

object named as

François-Clément Bidard

0 references

Jean-Charles Soria

3

object named as

Jean-Charles Soria

0 references

author name string

Jean-Yves Pierga

2

1 reference

PubMed ID

23381003

28 August 2017

Jean Paul Thiery

4

1 reference

PubMed ID

23381003

28 August 2017

language of work or name

English

0 references

publication date

5 February 2013

1 reference

Nature Reviews Clinical Oncology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

169-179

1 reference

28 August 2017

3

1 reference

Hallmarks of Cancer: The Next Generation

28 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Intravital microscopy: new insights into metastasis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

TNM-Classification for Lung Cancer: From the 7(th) to the 8(th) Edition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Molecular mechanisms of metastasis in breast cancer--clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Tumor metastasis: molecular insights and evolving paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Unravelling the complexity of metastasis - molecular understanding and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Expression of RHOC is associated with metastasis of gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Practical implications of gene-expression-based assays for breast oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Subtypes of breast cancer show preferential site of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene expression predictors in breast cancer: current status, limitations and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognostic signatures in breast cancer: correlation does not imply causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Predicting prostate cancer behavior using transcript profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Molecular classification of prostate cancer using curated expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Discovery of prostate cancer biomarkers by microarray gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Lung cancer genomic signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognostic gene signatures for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Copy number alterations that predict metastatic capability of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The changing view of high-grade serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Significance of biological resource collection and tumor tissue bank creation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

MicroRNAs in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Genes associated with breast cancer metastatic to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Models, mechanisms and clinical evidence for cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Controversies in clinical cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Circulating tumour cells in non-metastatic breast cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Challenges in the enumeration and phenotyping of CTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Microfluidic: an innovative tool for efficient cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Circulating tumor cells and circulating tumor DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

No common denominator for breast cancer lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Differential gene expression in primary breast tumors associated with lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

International network of cancer genome projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Genomics: the breast cancer landscape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Who's driving anyway? Herculean efforts to identify the drivers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Single-molecule sequencing of an individual human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Thinking outside the box: using metastasis suppressors as molecular tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Perspectives on classic article: metastasis suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Biomarker studies: a call for a comprehensive biomarker study registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Use of archived specimens in evaluation of prognostic and predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Biologic markers determine both the risk and the timing of recurrence in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Cancer dormancy: a model of early dissemination and late cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Real-time imaging reveals the single steps of brain metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Patient-derived tumour xenografts as models for oncology drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Preclinical development of molecular-targeted agents for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Effects of bone-targeted agents on cancer progression and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Perspective: The right trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prediction of cancer outcome with microarrays: a multiple random validation strategy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Metastasis-suppressor genes in clinical practice: lost in translation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

How a new stratified adaptive phase II design could improve targeting population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.4

Molecular signature associated with bone marrow micrometastasis in human breast cancer

31 March 2020

1 reference

12 December 2020

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

1 reference

12 December 2020

TNM-classification for lung cancer: from the 7th to the 8th edition

1 reference

12 December 2020

Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer

1 reference

12 December 2020

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCLINONC.2013.4

1 reference

28 August 2017

1 reference

PubMed ID

23381003